Our Mission...
is to improve the quality of health service delivery and reduce the burden of disease and disability in the United States and elsewhere by carrying out broadly based research and education activities involving the translation of innovative medical research into practice





Craig WY, Palomaki GE, Roberson M, Haddow JE: Further insights into implications of undetectable or very low unconjugated estriol in maternal serum during the second trimester. Prenat Diagn, 31:616-618, 2011.

Bradley LA, Palomaki GE, Bienstock J, Varga E, Scott JA: Can factor V Leiden and prothrombin G20210A testing in women with recurrent pregnancy loss result in improved pregnancy outcome? Results form a targeted evidence-based review. Genet Med, 2011 [Epub ahead of print].

Devaney SA , Palomaki GE, Scott JA, Bianchi DW: Noninvasive fetal sex determination using cell-free fetal DNA. A systematic review and analysis. JAMA, 306:627-636, 2011.

Haddow JE, McClain MR, Palomaki GE, Neveux LM, Lambert-Messerlian G, Canick JA, Malone FD, Porter TF, Nyberg DA, Bernstein PS, D’Alton ME for the First and Second Trimester Risk of Aneuoploidy (FaSTER) Research Consortium: Thyroperoxidase and thyroglobulin antibodies in early pregnancy and placental abruption. Obstet Gynecol, 117:287-292, 2011.

Haddow JE, Palomaki GE: An introduction to assessing genomic screening and diagnostic tests. Nutr Today, 46:162-168, 2011.

Haddow JE: The New American Thyroid Assocation Guidelines for Thyroid Disease During Prengnacy and Postpartum: A Blueprint for Improving Prenatal Care. Invited Editorial. Thyroid, 21:1047-1048, 2011.

Haddow JE , Neveux LM, Palomaki GE, Lambert-Messerlian G, Canick JA, Grenache DG, Lu J: The relationship between PTH and 25-Hydroxy vitamin D early in pregnancy. Clin Endocrinol (Oxf), 75:309-314, 2011.

Palomaki GE, Kloza EM, Lambert-Messerlian G, Haddow JE, Neveux LM, Ehrich M, van den Boom D, Bombard AT, Deciu C, Grody WW, Nelson SF, Canick JA: DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation trial. Genet Med, October 2011, [Epub ahead of print).

Palomaki GE, Richards CS: Assessing the analytic validity of molecular testing for Huntington disease using data from an external proficiency testing survey. Genet Med , October 2011, [Epub ahead of print].

Recommendations from the EGAPP Working Group: Routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members. Genet Med, 13:67-76, 2011.

Sprawka N, Lambert-Messerlian G, Palomaki GE, Eklund EE, Canick JA: Adjustment of maternal serum alpha-fetoprotein levels in women with pregestational diabetes. Prenat Diagn, 31:282-285, 2011.

Zhang J, Lambert-Messerlian G, Palomaki GE, Canick JA: Impact of smoking on maternal serum markers and prenatal screening in the first and second trimesters. Prenat Diagn, 31:583-588, 2011.